0001213900-24-099300.txt : 20241118 0001213900-24-099300.hdr.sgml : 20241118 20241115203302 ACCESSION NUMBER: 0001213900-24-099300 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20241118 DATE AS OF CHANGE: 20241115 EFFECTIVENESS DATE: 20241118 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Lomond Therapeutics Holdings, Inc. CENTRAL INDEX KEY: 0001900520 STANDARD INDUSTRIAL CLASSIFICATION: BLANK CHECKS [6770] ORGANIZATION NAME: 05 Real Estate & Construction IRS NUMBER: 872959575 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-529644 FILM NUMBER: 241469560 BUSINESS ADDRESS: STREET 1: C/O LOMOND THERAPEUTICS HOLDINGS, INC. STREET 2: 8 THE GREEN STE 8490 CITY: DOVER STATE: DE ZIP: 19901 BUSINESS PHONE: 561 464 2841 MAIL ADDRESS: STREET 1: C/O LOMOND THERAPEUTICS HOLDINGS, INC. STREET 2: 8 THE GREEN STE 8490 CITY: DOVER STATE: DE ZIP: 19901 FORMER COMPANY: FORMER CONFORMED NAME: Venetian-1 Acquisition Corp. DATE OF NAME CHANGE: 20211220 D 1 primary_doc.xml X0708 D LIVE 0001900520 Lomond Therapeutics Holdings, Inc. 8 THE GREEN STE 8490 DOVER DE DELAWARE 19901 212-739-6400 DELAWARE None Venetian-1 Acquisition Corp. Corporation true 2021 Iain Dukes 8 The Green Ste 8490 Dover DE DELAWARE 19901 Executive Officer Director Nikolay Savchuk 8 The Green Ste 8490 Dover DE DELAWARE 19901 Executive Officer Director Eddie Wang Rodriguez 8 The Green Ste 8490 Dover DE DELAWARE 19901 Director Carl Gordon 8 The Green Ste 8490 Dover DE DELAWARE 19901 Director Pharmaceuticals Decline to Disclose 06b false 2024-11-01 false true true The initial sale of the subject securities occurred concurrently with the closing of a reverse merger with Lomond Operating Co. Such securities were issued to accredited investors. 0 Raymond James & Associates, Inc. 000000705 None None 880 Carillon Parkway St. Petersburg FL FLORIDA 33716 All States false Wedbush & Co., LLC 000328492 None None 600 Montgomery Street, 29th Floor San Francisco CA CALIFORNIA 94111 All States true 43900000 43900000 0 $43.9 million shares of common stock, which included (i) 8,241,375 shares of common stock; (ii) 1,078,124 shares of common stock pursuant to the conversion of SAFEs, and (iii) 2,083,332 shares of common stock pursuant to conversion of SAFEs. false 27 2500000 true 0 In addition to the sales commissions, warrants to purchase an aggregate of 275,410 shares of our common stock were also issued to the placement agents. 0 false Lomond Therapeutics Holdings, Inc. /s/ Iain Dukes Iain Dukes Chief Executive Officer 2024-11-15